Location: | London |
---|---|
Salary: | £34,189 to £40,792 per annum inclusive of London Weighting Allowance per annum. |
Hours: | Full Time |
Contract Type: | Permanent |
Placed On: | 5th July 2024 |
---|---|
Closes: | 10th July 2024 |
Job Ref: | 092217 |
About the role:
The Senior QC Scientist will be responsible for the carrying out in-house quality control (QC) testing of cell and gene therapy products manufactured by the Cell and Gene Therapy (CGT) group as investigational medicinal products (IMPs) and as starting materials for further IMP manufacture. The role holder will ensure compliance of the QC testing with GLP, GMP and ICH guidelines as applicable. Assays will include but not be limited to, flow cytometry-based assays, cell proliferation assays, protein assays and western blots and molecular based methods e.g. QPCR.
The role holder will lead on the development, validation and establishment of a broad range of start-of-the-art new in-house QC assays and work with external collaborators / clients on the tech transfer of QC assays into the CGT group. The maintenance of stability programs in conjunction with the Head of Quality and supervision of members of the QC team will also be undertaken by the role holder.
This is a full time post and you will be offered an indefinite contract.
About you: (the candidate)
To be successful in this role, we are looking for candidates to have the following skills and experience:
Essential criteria
Desirable criteria
Closing date: 10 July 2024
Type / Role:
Subject Area(s):
Location(s):